Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021

Clin Kidney J. 2022 Mar 31;15(4):593-602. doi: 10.1093/ckj/sfac023. eCollection 2022 Apr.

Abstract

The year 2021 was the last full year of Alberto Ortiz's editorship at Clinical Kidney Journal (CKJ). On May 2022, Maria José Soler will start her term as the Editor-in-Chief. Over these years, CKJ obtained its first journal impact factor and has consolidated its position among the top journals in the field, consistently ranking among the top 25% (first quartile) journals in Urology and Nephrology. The 2020 journal impact factor rose to 4.45, becoming the top open access journal in Nephrology and the ninth ranked Nephrology journal overall. We now review the recent history of the journal and the most highly cited topics which include the epidemiology of kidney disease, chronic kidney disease topics, such as the assessment and treatment of chronic kidney disease, onconephrology, cardionephrology, glomerular disease, transplantation and coronavirus disease 2019 (COVID-19).

Keywords: Clinical Kidney Journal; ERA Registry; chronic kidney disease.

Publication types

  • Editorial